SU-F-T-133: Uniform Scanning Proton Therapy for Lung Cancer: Toxicity and Its Correlation with Dosimetry

2016 ◽  
Vol 43 (6Part14) ◽  
pp. 3492-3492
Author(s):  
Y Zheng ◽  
S Rana ◽  
G Larson
Keyword(s):  
Lung Cancer ◽  
Proton Therapy ◽  
Uniform Scanning

scholarly journals Dosimetric impact of number of treatment fields in uniform scanning proton therapy planning of lung cancer

2014 ◽  
Vol 39 (4) ◽  
pp. 212 ◽  
Author(s):  
Suresh Rana ◽  
Hilarie Simpson ◽  
Gary Larson ◽  
Yuanshui Zheng
Keyword(s):  
Lung Cancer ◽  
Proton Therapy ◽  
Therapy Planning ◽  
Uniform Scanning ◽  
Number Of Treatment

OC-0444: Impact of deformable image registration on inter-fractional variations in lung cancer proton therapy

2020 ◽  
Vol 152 ◽  
pp. S245
Author(s):  
L. Nenoff ◽  
C.O. Ribeiro ◽  
M. Matter ◽  
L. Hafner ◽  
A.C. Knopf ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Image Registration ◽  
Proton Therapy ◽  
Deformable Image Registration

Outcomes of Proton Therapy for Non-small Cell Lung Cancer in Patients with Interstitial Pneumonia

2021 ◽  
Author(s):  
Shingo Hashimoto ◽  
Hiromitsu Iwata ◽  
Yukiko Hattori ◽  
Koichiro Nakajima ◽  
Kento Nomura ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Cancer Treatment ◽  
Small Cell Lung Cancer ◽  
Interstitial Pneumonia ◽  
Proton Therapy ◽  
Small Cell ◽  
Small Cell Lung ◽  
Grade 3

Abstract Background:Interstitial pneumonia (IP) is a disease with a poor prognosis. In addition, IP patients are more likely to develop lung cancer. Since IP patients frequently develop toxicities during cancer treatment, minimally invasive cancer treatment is warranted for such patients to maintain their quality of life. This study retrospectively investigated the efficacy and safety of proton therapy (PT) for non-small cell lung cancer (NSCLC) in patients with IP.Methods:Twenty-nine NSCLC patients with IP were treated with PT between September 2013 and December 2019. The patients had stage IA to IIIB primary NSCLC. Ten of the 29 patients exhibited the usual interstitial pneumonia pattern. The prescribed dose was 66-74 Grays (relative biological effectiveness) in 10-37 fractions.Results:The median follow-up period was 17.4 months (interquartile range (IQR), 9.5–32.7). The median patient age was 77 years (IQR, 71–81). The median planning target volume was 112.0 ml (IQR, 56.1–246.3). The 2-year local control, progression-free survival, and overall survival rates were 77% (95% confidence interval: 34 to 94), 31% (13–50), and 50% (26–70), respectively. According to the Common Terminology Criteria for Adverse Events (version 4.0), grade 3 acute radiation pneumonitis (RP) was observed in 1 patient. Two patients developed grade 3 late RP, but no other patients experienced serious toxicities. The patients’ quality of life (European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-LC13 and SF-36) scores had not changed after 3 months.Conclusions:PT may safely control NSCLC without adversely affecting the daily lives of IP patients.

OC-0202 Influence of deformable propagated structures for lung cancer online daily adaptive proton therapy

2021 ◽  
Vol 161 ◽  
pp. S132-S133
Author(s):  
L. Nenoff ◽  
M. Matter ◽  
E.J. Amaya ◽  
M. Josipovic ◽  
A. Knopf ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Proton Therapy

Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy

2019 ◽  
Vol 132 ◽  
pp. 250-256 ◽  
Author(s):  
Leo Luo ◽  
John Cuaron ◽  
Lior Braunstein ◽  
Erin Gillespie ◽  
Atif Kahn ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Proton Therapy ◽  
Breast Cancer Patients ◽  
Uniform Scanning

The impact of 4DCT-ventilation imaging-guided proton therapy on stereotactic body radiotherapy for lung cancer

2020 ◽  
Vol 13 (3) ◽  
pp. 230-237
Author(s):  
Yoshiro Ieko ◽  
Noriyuki Kadoya ◽  
Takayuki Kanai ◽  
Yujiro Nakajima ◽  
Kazuhiro Arai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Proton Therapy ◽  
Stereotactic Body Radiotherapy ◽  
Ventilation Imaging ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document